Alternatives to QuantHealth

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.